1. Home
  2. VRTS vs INBX Comparison

VRTS vs INBX Comparison

Compare VRTS & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virtus Investment Partners Inc.

VRTS

Virtus Investment Partners Inc.

HOLD

Current Price

$145.78

Market Cap

968.0M

Sector

Finance

ML Signal

HOLD

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$103.07

Market Cap

999.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRTS
INBX
Founded
1988
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
968.0M
999.7M
IPO Year
1995
2024

Fundamental Metrics

Financial Performance
Metric
VRTS
INBX
Price
$145.78
$103.07
Analyst Decision
Hold
Buy
Analyst Count
4
3
Target Price
$158.00
$150.00
AVG Volume (30 Days)
71.5K
442.3K
Earning Date
05-01-2026
05-15-2026
Dividend Yield
6.68%
N/A
EPS Growth
18.24
N/A
EPS
1.05
N/A
Revenue
N/A
$1,300,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.66
N/A
P/E Ratio
$134.60
N/A
Revenue Growth
N/A
550.00
52 Week Low
$121.61
$12.80
52 Week High
$214.88
$155.29

Technical Indicators

Market Signals
Indicator
VRTS
INBX
Relative Strength Index (RSI) 54.35 45.50
Support Level $134.54 $99.20
Resistance Level $147.15 $153.14
Average True Range (ATR) 4.88 11.61
MACD 0.22 -3.13
Stochastic Oscillator 76.21 7.41

Price Performance

Historical Comparison
VRTS
INBX

About VRTS Virtus Investment Partners Inc.

Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: